Pyrimidine Nucleotide Collagen Promoter for Skin Barrier Bypass
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods to increase collagen production in the skin, such as oral ingestion of collagen and topical application of high molecular weight collagen, are ineffective due to collagen degradation in the digestive tract and inability to penetrate the skin, respectively, while current compositions using pyrimidine nucleotides are believed to have no collagen-promoting effect.
Innovation Solution
A collagen production promoter comprising pyrimidine nucleotides or their precursors, which are applied to the skin through epidermal cells to stimulate collagen production in fibroblasts, bypassing direct application to fibroblasts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If collagen is orally ingested to increase skin collagen, then collagen production is expected to increase, but collagen is decomposed in the digestive tract before absorption
Solution Approach 1:
The patent introduces nucleotide compounds (adenylic acid, uridylic acid, cytidylic acid) as intermediary substances that act as signaling molecules to stimulate fibroblasts to produce collagen, rather than directly supplying collagen protein. These nucleotides penetrate the skin barrier and trigger endogenous collagen synthesis, resolving the issue of external collagen inability to penetrate skin.
Solution Approach 2:
The patent replaces the mechanical approach of physically delivering collagen protein to the skin with a biochemical signaling approach using nucleotide compounds. Instead of relying on collagen molecules to penetrate skin barriers and be absorbed, the nucleotides serve as chemical signals that activate collagen production pathways within fibroblasts, achieving the same goal through a different mechanism.
2Quantity of substance
If high molecular weight collagen is applied topically to increase skin collagen, then collagen production is expected to increase, but collagen cannot penetrate the skin
Solution Approach 1:
The patent uses nucleotide compounds as intermediary signaling molecules that can penetrate the skin barrier and stimulate fibroblasts to produce collagen internally. This avoids the problem of large collagen molecules being blocked by the skin barrier, as the small nucleotide signals can pass through and trigger collagen synthesis from within.
Solution Approach 2:
Instead of trying to deliver collagen to the skin (external application), the patent inverts the approach by delivering signaling molecules that trigger internal collagen production. The nucleotide compounds are applied to the skin, penetrate the barrier, and then activate the skin's own fibroblasts to synthesize collagen, achieving the opposite sequence of delivery and production.
3Quantity of substance
If pyrimidine nucleotides are used to promote collagen production, then collagen production is expected to increase, but previous studies show pyrimidine nucleotides alone have no effect
Solution Approach 1:
The patent combines multiple nucleotide compounds (adenylic acid, uridylic acid, cytidylic acid) working synergistically to achieve robust collagen production. While individual pyrimidine nucleotides showed limited effect, the combination of all three nucleotides creates a comprehensive signaling system that strongly stimulates fibroblast collagen synthesis, overcoming the limitation of single-nucleotide effectiveness.
Solution Approach 2:
The patent employs a multi-functional nucleotide-based signaling system where adenylic acid, uridylic acid, and cytidylic acid each contribute different aspects of collagen production stimulation. This universal approach using multiple nucleotide types ensures reliable and robust collagen synthesis, as the combined action of different nucleotide signals provides comprehensive activation of collagen pathways.
Data Source
AI summary
A collagen production promoter contains at least one pyrimidine nucleotide or precursor thereof as an active ingredient.


